Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of combining ablation index-guided and very high-power short-duration ablation at posterior wall adjacent to esophagus during perioperative period on procedural factors.
Yano M, Egami Y, Abe M, Osuga M, Nohara H, Kawanami S, Ukita K, Kawamura A, Yasumoto K, Okamoto N, Matsunaga-Lee Y, Nishino M. Yano M, et al. Among authors: osuga m. J Cardiovasc Electrophysiol. 2024 Oct 30. doi: 10.1111/jce.16483. Online ahead of print. J Cardiovasc Electrophysiol. 2024. PMID: 39474661
Impact of residual induction number of non-pulmonary vein foci on the 2-year outcomes in patients with paroxysmal atrial fibrillation.
Egami Y, Abe M, Osuga M, Nohara H, Kawanami S, Ukita K, Kawamura A, Yasumoto K, Tsuda M, Okamoto N, Matsunaga-Lee Y, Yano M, Nishino M. Egami Y, et al. Among authors: osuga m. J Interv Card Electrophysiol. 2024 Oct;67(7):1615-1621. doi: 10.1007/s10840-024-01820-z. Epub 2024 May 4. J Interv Card Electrophysiol. 2024. PMID: 38703331
Is sinus rhythm maintenance after repeat catheter ablation effective in patients with atrial fibrillation and heart failure with preserved ejection fraction?
Egami Y, Kobayashi N, Sugino A, Abe M, Osuga M, Nohara H, Kawanami S, Ukita K, Kawamura A, Yasumoto K, Okamoto N, Matsunaga-Lee Y, Yano M, Nishino M. Egami Y, et al. Among authors: osuga m. J Cardiovasc Electrophysiol. 2024 Oct 16. doi: 10.1111/jce.16464. Online ahead of print. J Cardiovasc Electrophysiol. 2024. PMID: 39415328
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Taniguchi Y, et al. Among authors: osuga m. BMC Pulm Med. 2024 Aug 24;24(1):407. doi: 10.1186/s12890-024-03212-5. BMC Pulm Med. 2024. PMID: 39182046 Free PMC article.
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer.
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Tamiya A, et al. Among authors: osuga m. Lung Cancer. 2024 Sep;195:107917. doi: 10.1016/j.lungcan.2024.107917. Epub 2024 Aug 3. Lung Cancer. 2024. PMID: 39116552 Free article.
13 results